Latest news for Rein Therapeutics (NASDAQ:RNTX) Stock

Rein Therapeutics

Aileron Therapeutics

Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03, LTI-01, and others.

Rein Therapeutics Inc

VSME

VS Media SG To Acquire 21% Stake In S T Meng For 1.5M Class A Shares

Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) analyst Mark Delaney highlights the Model Y update, automotive market share, what consumers are saying in a new survey and key questions ahead of the company's fourth quarter earnings report on <a href="https://www.benzinga.com/earnings">Wednesday, Jan. 29.</a>
Tesla Model Y: The refreshed Model Y, which comes to the U.S. and Europe after a launch in China earlier this month, offers good upgrades, Goldman Sachs analyst Delaney said in the investor note.
The analyst maintained a Neutral rating with a price target of $345.
"Some of the changes made in the refresh, beyond the extended range, include updated exterior lighting, an added screen for the back seat, ambient lighting, and better outside noise reduction," Delaney said.
The analyst said a new camera on the front bumper could better assist with parking and also could be used for Autopilot and FSD. &nbsp;
Tesla is offering discounts on Model Y units in inventory ahead of the refresh launch in March.
"Mix and how fast Tesla ramps up production of the refreshed version will help determine the effect on blended ASPs. We believe the new version offers several good enhancements."
Read Also: <a href="https://www.benzinga.com/news/global/25/01/43172806/tesla-lost-15-billion-in-brand-value-in-2024-report-says-did-elon-musks-political-push-hurt-ev-giant">Tesla Lost $15 Billion In Brand Value In 2024, Report Says: Did Elon Musk&#8217;s Political Push Hurt EV Giant?</a>
Tesla Market Share: The analyst estimates Tesla's sales in the U.S. were flat in the fourth quarter on a year-over-year basis. Tesla's market share for the electric vehicle sector in the U.S. likely hit "the mid 40% range," Delaney said. This would be down from around 50% in the fourth quarter of 2023.
Delaney estimates Tesla's sales in the European market were down 10% year-over-year in the fourth quarter and its market share went from 16% in last year's fourth quarter to 13% in this most recent fourth quarter.
The analyst said Tesla's sales in China are estimated up 16% year-over-year in the fourth quarter and the company had a high-single-digit percentage market share for battery-powered electric vehicles.
Consumer Feedback Survey: Delaney uses data from a HundredX consumer feedback survey to predict Tesla's demand.
"The survey data still shows a decline for Tesla in the brand/trust metric, whereas the score for the broader industry have been relatively stable. Similarly, Tesla's net purchase intent scores have declined by more than the peer group," Delaney said.
The analyst said items like new vehicles and Full Self Driving are keys in potentially reversing the Tesla scores going forward.
Key Items to Watch: Ahead of Tesla's fourth-quarter financial results, Delaney highlights the top items to watch.
These are the analyst&#8217;s key topics for the earnings report:
<ol>
<li>Automotive non-GAAP gross margins</li>
<li>Vehicle delivery outlook for 2025</li>
<li>Progress with FSD and AI-related efforts</li>
<li>Growth in other segments, including Services and Energy</li>
<li>Progress with Optimus and expectations on ramp timing</li>
</ol>
"We believe a key debate in the market will be whether Tesla can grow more meaningfully in 2025/2026, driven by a refreshed Model Y and a new lower-cost model or models," Delaney said.
The analyst said Tesla is targeting 20% to 30% year-over-year growth in deliveries in 2025.
Delaney said the potential end of the $7,500 federal tax credit for electric vehicles could be a key topic in the company commentary.
On the AI front, Delaney said Tesla is unlikely to hit a goal of being safer than human drivers in the second quarter of 2025. The analyst also questions Tesla's timeline launch of the Cybercab robotaxi in 2026.
"We expect Tesla to begin very limited robotaxi operations in 2H26."
TSLA Price Action: Tesla stock is down 3.02% to $394.62 on Monday versus a 52-week trading range of $138.80 to $488.54. Tesla stock is up about 110% over the past year.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/42856115/tesla-analyst-on-high-stakes-future-optimus-robotaxi-fsd-have-potential-but-execution-risks-loom">Tesla Analyst On High-Stakes Future: Optimus, Robotaxi, FSD Have Potential, But Execution Risks Loom</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Earnings

Price Target

Previews

Reiteration

Analyst Ratings

Trading Ideas

TSLA

Tesla Analyst's Top 5 Items To Watch In Q4 Earnings: Will Refreshed Model Y, New EVs Help Growth?

Deep-pocketed investors have adopted a bearish approach towards Pinterest (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINS#NYSE">PINS</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in PINS usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 11 extraordinary options activities for Pinterest. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 27% leaning bullish and 45% bearish. Among these notable options, 3 are puts, totaling $107,666, and 8 are calls, amounting to $725,015.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $25.0 to $50.0 for Pinterest during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Pinterest's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Pinterest's substantial trades, within a strike price spectrum from $25.0 to $50.0 over the preceding 30 days.
<h3>Pinterest 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738005326_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PINS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$1.97</td>
<td>$1.6</td>
<td>$1.68</td>
<td>$35.00</td>
<td>$178.1K</td>
<td>5.2K</td>
<td>1.0K</td>
</tr>
<tr>
<td>PINS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$1.17</td>
<td>$1.14</td>
<td>$1.17</td>
<td>$37.00</td>
<td>$172.0K</td>
<td>998</td>
<td>1.4K</td>
</tr>
<tr>
<td>PINS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$1.83</td>
<td>$1.7</td>
<td>$1.7</td>
<td>$35.00</td>
<td>$129.2K</td>
<td>5.2K</td>
<td>1.8K</td>
</tr>
<tr>
<td>PINS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$1.74</td>
<td>$1.7</td>
<td>$1.74</td>
<td>$35.00</td>
<td>$91.1K</td>
<td>5.2K</td>
<td>1.6K</td>
</tr>
<tr>
<td>PINS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/31/25</td>
<td>$0.44</td>
<td>$0.42</td>
<td>$0.43</td>
<td>$32.50</td>
<td>$44.1K</td>
<td>4.1K</td>
<td>225</td>
</tr>
</tbody>
</table>

<h3>About Pinterest</h3>
Pinterest is a social media platform with a focus on product and idea discovery. Pinterest users, or pinners, can leverage the platform as they go about gathering ideas on topics such as home improvement, fashion, cooking, and travel. The company has more than 500 million monthly active users, two thirds of whom are female. Pinterest generates revenue by selling digital ads on its platform. While the platform's user base spans the globe, the vast majority of its revenue stems from ads shown to North American users.
After a thorough review of the options trading surrounding Pinterest, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of Pinterest</h3>
<ul>
<li>With a volume of 4,328,891, the price of PINS is up 0.91% at $33.2. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 10 days.</li>
</ul>
<h3>What Analysts Are Saying About Pinterest</h3>
A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $36.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Morgan Stanley keeps a Equal-Weight rating on Pinterest with a target price of $36. 
&#x2A; An analyst from Jefferies has revised its rating downward to Hold, adjusting the price target to $32. 
&#x2A; An analyst from Keybanc persists with their Overweight rating on Pinterest, maintaining a target price of $37. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on Pinterest, which currently sits at a price target of $39. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Pinterest, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

PINS

Check Out What Whales Are Doing With PINS

Whales with a lot of money to spend have taken a noticeably bullish stance on Western Digital.
Looking at options history for Western Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDC#NASDAQ">WDC</a>) we detected 16 trades.
If we consider the specifics of each trade, it is accurate to state that 68% of the investors opened trades with bullish expectations and 31% with bearish.
From the overall spotted trades, 5 are puts, for a total amount of $355,746 and 11, calls, for a total amount of $565,725.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $58.0 to $75.0 for Western Digital over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Western Digital options trades today is 4491.0 with a total volume of 11,190.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Western Digital's big money trades within a strike price range of $58.0 to $75.0 over the last 30 days.
<h3>Western Digital Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738005322_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>WDC</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$4.1</td>
<td>$4.0</td>
<td>$4.1</td>
<td>$65.00</td>
<td>$215.2K</td>
<td>1.0K</td>
<td>3.0K</td>
</tr>
<tr>
<td>WDC</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$3.45</td>
<td>$3.2</td>
<td>$3.3</td>
<td>$65.00</td>
<td>$164.6K</td>
<td>4.6K</td>
<td>503</td>
</tr>
<tr>
<td>WDC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$3.55</td>
<td>$3.35</td>
<td>$3.38</td>
<td>$65.00</td>
<td>$84.7K</td>
<td>4.6K</td>
<td>753</td>
</tr>
<tr>
<td>WDC</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$2.1</td>
<td>$1.95</td>
<td>$2.04</td>
<td>$75.00</td>
<td>$47.9K</td>
<td>16.8K</td>
<td>235</td>
</tr>
<tr>
<td>WDC</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$2.03</td>
<td>$2.0</td>
<td>$2.0</td>
<td>$75.00</td>
<td>$46.0K</td>
<td>16.8K</td>
<td>678</td>
</tr>
</tbody>
</table>

<h3>About Western Digital</h3>
Western Digital is a leading vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.
Having examined the options trading patterns of Western Digital, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Western Digital's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 4,141,118, the WDC's price is down by -2.69%, now at $65.6. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 2 days.</li>
</ul>
<h3>What The Experts Say On Western Digital</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $85.2.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from B of A Securities has decided to maintain their Buy rating on Western Digital, which currently sits at a price target of $84. 
&#x2A; An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $95. 
&#x2A; An analyst from Mizuho has decided to maintain their Outperform rating on Western Digital, which currently sits at a price target of $82. 
&#x2A; An analyst from B of A Securities has decided to maintain their Buy rating on Western Digital, which currently sits at a price target of $80. 
&#x2A; Consistent in their evaluation, an analyst from Wells Fargo keeps a Overweight rating on Western Digital with a target price of $85. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Western Digital with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Behind the Scenes of Western Digital's Latest Options Trends

Financial giants have made a conspicuous bullish move on Rio Tinto. Our analysis of options history for Rio Tinto (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIO#NYSE">RIO</a>) revealed 11 unusual trades.
Delving into the details, we found 54% of traders were bullish, while 27% showed bearish tendencies. Out of all the trades we spotted, 9 were puts, with a value of $928,577, and 2 were calls, valued at $69,620.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $52.5 to $75.0 for Rio Tinto over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
In today's trading context, the average open interest for options of Rio Tinto stands at 1673.56, with a total volume reaching 2,468.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Rio Tinto, situated within the strike price corridor from $52.5 to $75.0, throughout the last 30 days.
<h3>Rio Tinto Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738005316_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>RIO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$15.4</td>
<td>$13.6</td>
<td>$15.2</td>
<td>$75.00</td>
<td>$466.6K</td>
<td>136</td>
<td align="right">308</td>
</tr>
<tr>
<td>RIO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$2.55</td>
<td>$2.45</td>
<td>$2.45</td>
<td>$57.50</td>
<td>$109.5K</td>
<td>1.6K</td>
<td align="right">542</td>
</tr>
<tr>
<td>RIO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$3.6</td>
<td>$3.5</td>
<td>$3.5</td>
<td>$60.00</td>
<td>$87.8K</td>
<td>9.1K</td>
<td align="right">294</td>
</tr>
<tr>
<td>RIO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$4.8</td>
<td>$4.7</td>
<td>$4.8</td>
<td>$57.50</td>
<td>$65.7K</td>
<td>440</td>
<td align="right">138</td>
</tr>
<tr>
<td>RIO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$3.5</td>
<td>$1.6</td>
<td>$3.5</td>
<td>$60.00</td>
<td>$60.5K</td>
<td>9.1K</td>
<td align="right">467</td>
</tr>
</tbody>
</table>

<h3>About Rio Tinto</h3>
Rio Tinto is a global diversified miner. Iron ore is the dominant commodity, with significantly lesser contributions from copper, aluminum, diamonds, gold, and industrial minerals. The 1995 merger of RTZ and CRA, via a dual-listed structure, created the present-day company. The two operate as a single business entity, with shareholders in each company having equivalent economic and voting rights. Major assets included the Pilbara iron ore operations, a 30% stake in the Escondida copper mine, 66%-ownership of the Oyu Tolgoi copper mine in Mongolia, the Weipa and Gove bauxite mines in Australia, and six hydro-powered aluminum smelters in Canada.
In light of the recent options history for Rio Tinto, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Rio Tinto's Current Market Status</h3>
<ul>
<li>With a volume of 1,445,321, the price of RIO is down -0.81% at $61.59. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 23 days.</li>
</ul>
<h3>What Analysts Are Saying About Rio Tinto</h3>
1 market experts have recently issued ratings for this stock, with a consensus target price of $73.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Jefferies continues to hold a Buy rating for Rio Tinto, targeting a price of $73. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Rio Tinto with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Rio Tinto Unusual Options Activity

BofA Securities analyst Rafe Jadrosich downgraded D.R. Horton, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>) and Smith Douglas Homes Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SDHC#NYSE">SDHC</a>), citing a tough outlook for homebuilder stocks <a target="_blank" href="https://www.benzinga.com/analyst-stock-ratings" rel="noreferrer noopener">as the spring selling season approaches</a>.
Notably, the analyst says that Homebuilder stocks lagged the market in 2024 due to declining demand in the second half of the year, driven by higher mortgage rates.
The analyst anticipates the tough environment for homebuilders will continue through the first half of 2025.
The analyst expects return-on-equity to decline in 2025 for seven out of eight homebuilders, with order growth impacting margins.
The analyst&#8217;s top picks in builders are Toll Brothers, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOL#NYSE">TOL</a>) and NVR, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVR#NYSE">NVR</a>). TOL&#8217;s valuation is attractive compared to other builders with similar or lower ROE. NVR is the only builder in the analyst&#8217;s coverage universe that can hold ROE flat in 2025 vs. 2024.
Housing markets in the Northeast, Midwest, and Mid-Atlantic should outperform the Southeast and other regions, while the move-up and luxury segments are set to outperform entry-level markets, adds the analyst.
DHI: The analyst downgraded D.R. Horton from Buy to Neutral and cut the <a target="_blank" href="https://www.benzinga.com/quote/DHI/analyst-ratings" rel="noreferrer noopener">price forecast from $160 to $150</a>.
The analyst writes that lot costs, which make up 26%-27% of total costs, are rising (+3% QoQ, +10% YoY in first-quarter), and DHI expects similar inflation before moderating to mid-to-high single digits on year in the next couple of quarters.
Due to the tough housing macro (higher rates, more supply), DHI may struggle to raise prices to offset lot cost inflation, adds the analyst.
The analyst says that DHI is no longer investing in its rental segment, but rental inventory already accounts for 11% of book value.
Jadrosich expects a low single-digit ROE for rentals in 2025, which will drag overall ROE by &gt;100bps.
Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/25/01/43095811/d-r-horton-q1-earnings-beat-despite-soft-housing-market-fy25-outlook-reiterated" rel="noreferrer noopener">D.R. Horton Q1: Earnings Beat Despite Soft Housing Market, FY25 Outlook Reiterated</a>
SDHC: The analyst downgraded the company from Neutral to Underperform and cut the <a target="_blank" href="https://www.benzinga.com/quote/sdhc/analyst-ratings" rel="noreferrer noopener">price forecast from $33 to $22</a>.
Jadrosich says that, like other builders, SDHC faces cost inflation headwinds while higher mortgage rates pressure net prices.
While ~15% community count growth and faster build cycles provide delivery tailwinds, the analyst notes absorptions will also need to improve to meet the guidance.
The valuation appears less compelling compared to peers, given the expectation that Smith Douglas&#8217; delivery growth will moderate in 2025 and its ROE will normalize closer to the group average, adds the analyst.
The analyst expect delivery growth of around 4% in 2025 vs. preliminary guidance of roughly 11% at the mid-point.
Jadrosich expects Smith Douglas to enter 2025 with a backlog that is down roughly 13% YoY.
Price Action: DHI shares are up 2.64% at $146.69, while SDHC sharesa re down 0.37% at $24.22 at the last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/25/01/43120493/dow-jumps-over-500-points-as-trump-takes-office-investor-sentiment-improves-but-greed-index-remains-in-fear-zone" target="_blank" rel="noreferrer noopener">Dow Jumps Over 500 Points As Trump Takes Office: Investor Sentiment Improves, But Greed Index Remains In &#8216;Fear&#8217; Zone</a></li>
</ul>
Image via Shutterstock.

Equities

Large Cap

News

Downgrades

General

SDHC

Homebuilders Brace For Tough 2025, Analyst Downgrades D.R. Horton And Smith Douglas Amid Market Pressures

NVDA

Nvidia Spokesperson Says DeepSeek's Work Shows How New Models Can Be Created, Leveraging Widely-Available Models And Compute That Is Fully Export Control Compliant

Toshi (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TOSHI</a>), a meme coin named after Coinbase co-founder Brian Armstrong, has outperformed meme coin heavyweights like Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) and Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>) over the past week, seeing stellar gains after being <a href="https://www.benzinga.com/quote/COIN">listed on Coinbase</a>.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Toshi (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TOSHI</a>)</td>
<td>&nbsp;$0.00117</td>
<td>$477.8 million</td>
<td>-31.7%&nbsp;</td>
<td>&nbsp;+224.1%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.319&nbsp;</td>
<td>$47 billion</td>
<td>-10%&nbsp;</td>
<td>-12.3%&nbsp;</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>&nbsp;$0.00001819</td>
<td>$10.7 billion</td>
<td>-8.8%&nbsp;</td>
<td>-11.7%&nbsp;</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto trader BasedTricky emphasized Toshi's strong performance despite market dips, pointing to its impressive $1 billion 24-hour trading volume. 
He <a href="https://x.com/BasedTricky/status/1883873858815463918">predicts</a> that Toshi, dubbed the &#8220;Face of Coinbase,&#8221; could experience a strong rebound as market conditions stabilize.
Another crypto trader, Pennski Hardaway, believes Toshi could redefine the meme coin landscape, especially within Ethereum Virtual Machine (EVM) chains, if it crosses the $1 billion market cap. 
He <a href="https://x.com/0x_Imperius/status/1882588299010908500">sees</a> Toshi as a transformative force that could reignite innovation and enthusiasm in the space, while strengthening Coinbase's position in the crypto industry.
Statistics: Crypto trader rb3k <a href="https://x.com/rbthreek/status/1883333311952777514">noted</a> that the meme coin Toshi occupied the top spot in volume trading on Jan. 26, even outperforming Bitcoin in terms of trading volume.
Over the past seven days, Toshi has accumulated 220% gains leaving behind meme coin leaders like Dogecoin, Shiba Inu and Pepe (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>).
Community News: On Jan. 23, Coinbase officially announced Toshi's listing, propelling the token to an all-time high of $0.002273.
However, after a weekend rally, the coin faced a 32% decline in a single day, highlighting its volatility amid broader market uncertainty.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43105356/meme-coin-supercycle-dogecoin-trump-bonk-futures-etf-applications-filed">Meme Coin Supercycle? Dogecoin, Trump, Bonk Futures ETF Applications Filed</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

$PEPE

$SHIB

$TOSHI

Coinbase's Toshi Cat Coin Leaps Past Dogecoin, Shiba Inu With 200% Surge In One Week

BofA Securities analyst downgraded the shares of Bloomin&#8217; Brands Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMN#NASDAQ">BLMN</a>) from Neutral to Underperform and <a target="_blank" href="https://www.benzinga.com/quote/BLMN/analyst-ratings" rel="noreferrer noopener">lowered the price forecast from $18.00 to $13.00.</a>
Over the last decade, Bloomin&#8217;s transaction growth has averaged a decline of approximately 2% per year across its brands, with its largest brand, Outback, seeing a -1.1% compound annual growth rate (CAGR) in traffic, said the analyst.
Outback US accounted for about 51% of Bloomin&#8217;s (BLMN) revenue in FY24, and following the Brazil licensing, this is expected to rise to around 53%.
Also Read: <a href="https://www.benzinga.com//node/43241652">Starbucks Q1 Earnings Preview: Data Shows Visits Down, Will Company Continue Streak Of Missing Revenue Estimates?</a>
While the casual dining sector generally experiences slow growth, Bloomin&#8217;s challenges have allowed competitors to gain a larger market share. The new management&#8217;s primary focus is on reversing the decline in traffic, noted the analyst.
Although BLMN&#8217;s volumes have consistently decreased, its margins have remained unexpectedly strong. Domestic same-store transaction counts across the BLMN system are roughly 10% lower than in 2019, but restaurant margins have only dropped by 70 basis points.
With flow-through margins around 40% on additional transactions, the analyst would have anticipated a margin decline closer to 260 basis points compared to 2019.
The fact that their pricing has been on par with or higher than direct competitors such as Texas Roadhouse Inc in the steak category, supports this perspective.
While turnarounds in casual dining are uncommon, they are not unattainable, as demonstrated by Chili&#8217;s. However, its parent company, Brinker International Inc made substantial investments in labor to enhance service and marketing efforts to attract customers.
To balance this, Brinker implemented significant price hikes. In contrast, the analyst notes an important difference between Chili&#8217;s and Bloomin&#8217; is that Chili&#8217;s had historically underpriced its competitors.
Bloomin&#8217;s brands, on the other hand, have maintained competitive pricing and lack the scale advantages within their segments to outspend rivals on marketing or value without compromising margins.
Although BLMN is currently priced below its historical average, the analyst anticipates that both revenue and earnings projections will continue to face pressure in the near future.
Price Action: BLMN shares are trading lower by 0.36% at $12.27 at the last check Monday.
Photo via Shutterstock.

BLMN

TXRH

Bloomin' Brands Faces Near-Term Pressure, Analyst Highlights Peer Brinker's Turnaround Roadmap

Ahead of their earnings release, BofA Securities analyst Lawson Winder upgraded Kinross Gold Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KGC#NYSE">KGC</a>) and downgraded Barrick Gold Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOLD#NYSE">GOLD</a>).
Talking about market, the analyst says that Gold opened at $2,706/oz last week, rising to $2,746/oz on January 21, 2025, as the U.S. Dollar weakened.
It closed the week at $2,771/oz, up 2.5%, on President Trump&#8217;s remarks on a less aggressive tariff approach to China.
KGC: The analyst double-upgraded Kinross from Underperform to Buy and raised the price <a target="_blank" href="https://www.benzinga.com/quote/kgc/analyst-ratings" rel="noreferrer noopener">forecast from $9.25 to $12.75</a>.
The analyst notes several concerns surrounding Kinross, such as shorter mine life, maintaining 2 million gold equivalent ounces (GEOs) of annual production, and unit costs, are being addressed.
Consequently, the analyst raised the 2026 GEO production forecast from 1.8 million to 2 million GEO and increased earnings per share (EPS) estimates from $0.64 to $0.78 for 2026.
Despite market concerns about potential corporate acquisitions, Kinross remains disciplined in this regard, adds the analyst.
Additionally, Winder sees potential for Kinross to boost capital returns in 2025 through a share buyback. Overall, the analyst says that the company is well-positioned for fourth-quarter results with potential catalysts in 2025.
GOLD: The analyst downgraded the stock from Buy to Neutral and cut the <a target="_blank" href="https://www.benzinga.com/quote/gold/analyst-ratings" rel="noreferrer noopener">price forecast from $21 to $18</a>.
The analyst writes that as approaching fourth-quarter results, risks are rising, particularly regarding the shutdown of the Loulo-Gounkoto mine in Mali, and the struggling ramp-up of the Pueblo Viejo mine in the Dominican Republic.
In their 2025 model, Winder removed any production from the Loulo-Gounkoto mine due to its suspension amid a tax dispute with the Malian military government.
The analyst says that he sees two possible outcomes: the first, a less favorable tax and royalty agreement allowing continued operation; the second, a complete loss of operations if the government seizes control.
The analyst assumes the mine to restart in late 2025, ramping up to full production in 2026, but under less favorable terms for Barrick Gold.
Consequently, the analyst lowered 2025 estimates for EPS to $1.55 from $1.91 and 2026 EPS to $1.81 from $1.92.
Both Kinross and Barrick Gold will release their fourth-quarter results on <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">Wednesday, February 12, 2025</a>.
Price Action: KGC shares are down 0.89% at $10.60, while GOLD shares are down 1.18% at $15.94 at the last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/guidance/25/01/43093586/barrick-looks-into-portfolio-optimization-sees-pakistan-as-the-new-frontier" target="_blank" rel="noreferrer noopener">Barrick Looks Into Portfolio Optimization, Sees Pakistan As &#8216;The New Frontier&#8217;</a></li>
</ul>
Image via Shutterstock.

Upgrades

GOLD

Kinross Gold's Production Outlook Improves, Analyst Double Upgrades Stock

On Monday, Allakos Inc (NASDAQ:&nbsp;ALLK) revealed topline results from its phase 1 clinical trial of AK006 in chronic spontaneous urticaria <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/g41280699/allakos-announces-phase-1-trial-results-of-subcutaneous-ak006-in-healthy-volunteers" rel="noreferrer noopener">(CSU), a skin disorder</a>.
&#8220;While AK006 was well tolerated, we are disappointed that the preclinical inhibitory effects observed did not translate to clinical benefit in patients with CSU. As a result, the company has decided to discontinue further clinical development of AK006,&#8221; said Chin Lee, Chief Medical Officer of Allakos.
In the CSU cohort, 34 adult patients refractory to antihistamines with or without prior exposure to omalizumab were enrolled and randomized 2:1 to receive 720 mg of intravenous AK006 (n=23) or placebo (n=11) once every four weeks (Q4W).
AK006 was well-tolerated with a favorable safety profile. There were no serious adverse events (SAEs) in subjects on AK006.
The company plans to discontinue AK006-related activities across clinical, manufacturing, research, and administrative functions and reduce its workforce by approximately 75%.
The company plans to retain approximately 15 employees to explore strategic alternatives, maintain compliance with regulatory and financial reporting requirements, and wind down the phase 1 clinical trial.
In October, &nbsp;Allakos released results from the Phase 1 study of subcutaneous AK006 in healthy volunteers. Subcutaneously administered AK006 showed approximately 77% bioavailability and prolonged receptor occupancy on mast cells and was well-tolerated with a <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/g41280699/allakos-announces-phase-1-trial-results-of-subcutaneous-ak006-in-healthy-volunteers" rel="noreferrer noopener">favorable safety profile</a>.
Allakos ended the fourth quarter of 2024 with approximately $81 million in cash, cash equivalents, and investments. The company estimates that cash used in restructuring activities to close out AK006 development, including severance and contractual payments to vendors, will be approximately $34 million to $38 million.
The company also estimates that most of these restructuring costs will be paid over the first and second quarters of 2025.
Allakos estimates that as of June 30, 2025, it will have cash, cash equivalents, and investments of approximately $35 million to $40 million.
Price Action: ALLK stock is down 78.5% at $0.26 at last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43237896/vci-global-expands-ai-infrastructure-with-25m-investment" target="_blank" rel="noreferrer noopener">VCI Global Expands AI Infrastructure With $25M Investment</a></li>
</ul>

Biotech

Health Care

Movers

ALLK

Why Is Allakos Stock Plunging On Monday?

Across the recent three months, 7 analysts have shared their insights on Bloomin Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMN#NASDAQ">BLMN</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $14.43, a high estimate of $19.00, and a low estimate of $13.00. Observing a downward trend, the current average is 22.71% lower than the prior average price target of $18.67. 
<img src="https://www.benzinga.com/files/images/story/2025/1738004457_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The analysis of recent analyst actions sheds light on the perception of Bloomin Brands by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Justin Post</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$13.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Dennis Geiger</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$13.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Jeffrey Bernstein</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$13.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Christine Cho</td>
<td>Goldman Sachs</td>
<td>Announces</td>
<td>Sell</td>
<td>$13.00</td>
<td>-</td>
</tr>
<tr>
<td>John Ivankoe</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$14.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Jeffrey Bernstein</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$19.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Brian Mullan</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$16.00</td>
<td>$20.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Bloomin Brands. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Bloomin Brands compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Bloomin Brands's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/BLMN/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Bloomin Brands analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Unveiling the Story Behind Bloomin Brands</h2>
Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.
<h3>Bloomin Brands's Financial Performance</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3 months period, Bloomin Brands faced challenges, resulting in a decline of approximately -3.8% in revenue growth as of 30 September, 2024. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Discretionary sector.
Net Margin: Bloomin Brands's net margin excels beyond industry benchmarks, reaching 0.67%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Bloomin Brands's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 2.61%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Bloomin Brands's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.2%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a below-average debt-to-equity ratio of 9.93, Bloomin Brands adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Basics of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Bloomin Brands Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)

Throughout the last three months, 4 analysts have evaluated Nexxen International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXN#NASDAQ">NEXN</a>), offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $11.38, with a high estimate of $13.00 and a low estimate of $9.50. Marking an increase of 13.8%, the current average surpasses the previous average price target of $10.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1738004450_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of Nexxen International among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Greg Miller</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$11.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Matthew Swanson</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$13.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$12.00</td>
<td>$9.50</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$9.50</td>
<td>$8.50</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Nexxen International. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Nexxen International compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Nexxen International's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Nexxen International's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/NEXN/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Nexxen International analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>About Nexxen International</h2>
Nexxen International Ltd empowers advertisers, agencies, publishers, and broadcasters to utilize video and connected TV. It is a demand-side platform (DSP), supply-side platform (SSP), ad server, and data management platform (DMP) and also delivers a flexible and unified technology stack with advanced and exclusive data at its core.
<h3>A Deep Dive into Nexxen International's Financials</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Nexxen International displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 1.81%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Communication Services sector.
Net Margin: Nexxen International's net margin is impressive, surpassing industry averages. With a net margin of 16.12%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Nexxen International's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 2.78%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.81%, the company showcases effective utilization of assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.07.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

NEXN

4 Analysts Assess Nexxen International: What You Need To Know

Ratings for Ventas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTR#NYSE">VTR</a>) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $67.0, a high estimate of $69.00, and a low estimate of $65.00. This current average has decreased by 0.74% from the previous average price target of $67.50. 
<img src="https://www.benzinga.com/files/images/story/2025/1738004441_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The analysis of recent analyst actions sheds light on the perception of Ventas by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nicholas Yulico</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$69.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>David Rodgers</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$65.00</td>
<td>$66.00</td>
</tr>
<tr>
<td>David Rodgers</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$66.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Vikram Malhorta</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$68.00</td>
<td>$71.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Ventas. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Ventas compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Ventas's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Ventas's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/VTR/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Ventas analyst ratings.</a>
<h2>All You Need to Know About Ventas</h2>
Ventas owns a diversified healthcare portfolio of over 1,300 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
<h3>Financial Insights: Ventas</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Revenue Growth: Ventas displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 7.52%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Real Estate sector.
Net Margin: Ventas's net margin excels beyond industry benchmarks, reaching 1.56%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Ventas's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 0.2%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Ventas's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.08% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Ventas's debt-to-equity ratio is below the industry average at 1.42, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 4 Analysts Discuss Ventas Stock

Across the recent three months, 5 analysts have shared their insights on CenterPoint Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNP#NYSE">CNP</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for CenterPoint Energy, revealing an average target of $33.5, a high estimate of $37.00, and a low estimate of $30.00. Surpassing the previous average price target of $30.50, the current average has increased by 9.84%.
<img src="https://www.benzinga.com/files/images/story/2025/1738004430_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of CenterPoint Energy among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nicholas Campanella</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$30.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Paul Fremont</td>
<td>Ladenburg Thalmann</td>
<td>Announces</td>
<td>Buy</td>
<td>$34.50</td>
<td>-</td>
</tr>
<tr>
<td>Andrew Weisel</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Outperform</td>
<td>$35.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>William Appicelli</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$37.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>David Arcaro</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$31.00</td>
<td>$32.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to CenterPoint Energy. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of CenterPoint Energy compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for CenterPoint Energy's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of CenterPoint Energy's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CNP/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on CenterPoint Energy analyst ratings.</a>
<h2>Unveiling the Story Behind CenterPoint Energy</h2>
CenterPoint Energy owns a portfolio of businesses. Its regulated electric utilities provide transmission and distribution services to more than 2.5 million customers in the Houston area, southern Indiana, and west central Ohio. The company has natural gas distribution systems serving approximately 4 million customers.
<h3>CenterPoint Energy: A Financial Overview</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3 months period, CenterPoint Energy faced challenges, resulting in a decline of approximately -0.22% in revenue growth as of 30 September, 2024. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Utilities sector.
Net Margin: CenterPoint Energy's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 10.4%, the company may face hurdles in effective cost management.
Return on Equity (ROE): CenterPoint Energy's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 1.85%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): CenterPoint Energy's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.46%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.89.
<h2>What Are Analyst Ratings?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Forecasting The Future: 5 Analyst Projections For CenterPoint Energy

Rambus's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NYSE">RMBS</a>) short percent of float has fallen 11.91% since its last report. The company recently reported that it has 2.81 million shares sold short, which is 3.55% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.79 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Rambus Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738004423_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Rambus has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Rambus's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Rambus's peer group average for short interest as a percentage of float is 9.36%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

RMBS

(RMBS) - Analyzing Rambus's Short Interest

Consolidated Edison (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ED#NYSE">ED</a>) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $94.0, along with a high estimate of $100.00 and a low estimate of $85.00. A 1.31% drop is evident in the current average compared to the previous average price target of $95.25. 
<img src="https://www.benzinga.com/files/images/story/2025/1738004422_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Consolidated Edison. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nicholas Campanella</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$92.00</td>
<td>$99.00</td>
</tr>
<tr>
<td>Andrew Weisel</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$100.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>David Arcaro</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$85.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>Nicholas Campanella</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$99.00</td>
<td>$104.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Consolidated Edison. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Consolidated Edison compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Consolidated Edison's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ED/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Consolidated Edison analyst ratings.</a>
<h2>Get to Know Consolidated Edison Better</h2>
Con Ed is a holding company for Consolidated Edison of New York, or CECONY, and Orange &amp; Rockland, or O&amp;R. These utilities provide steam, natural gas, and electricity to customers in southeastern New York—including New York City—and small parts of New Jersey. The two utilities generate nearly all of Con Ed's earnings following the sale of its clean energy business to RWE in early 2023.
<h3>Consolidated Edison's Financial Performance</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Revenue Growth: Consolidated Edison displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 5.68%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Utilities sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 14.37%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Consolidated Edison's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.71% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 0.86%, the company showcases effective utilization of assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.2.
<h2>What Are Analyst Ratings?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

4 Analysts Assess Consolidated Edison: What You Need To Know

Primerica's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRI#NYSE">PRI</a>) short percent of float has fallen 6.47% since its last report. The company recently reported that it has 335 thousand shares sold short, which is 1.3% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.52 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Primerica Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738004418_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Primerica has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Primerica's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Primerica's peer group average for short interest as a percentage of float is 2.36%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Primerica?

Snow Lake Resources's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LITM#NYSE">LITM</a>) short percent of float has risen 4.56% since its last report. The company recently reported that it has 2.24 million shares sold short, which is 3.21% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Snow Lake Resources Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738004412_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Snow Lake Resources has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Snow Lake Resources's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Snow Lake Resources's peer group average for short interest as a percentage of float is 4.72%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

LITM

How Is The Market Feeling About Snow Lake Resources?

Across the recent three months, 21 analysts have shared their insights on Bloom Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">10</td>
<td align="right">6</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">7</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $23.52, a high estimate of $33.00, and a low estimate of $7.00. Witnessing a positive shift, the current average has risen by 50.0% from the previous average price target of $15.68.
<img src="https://www.benzinga.com/files/images/story/2025/1738004412_0_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Bloom Energy. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kashy Harrison</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$33.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Mark Strouse</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$16.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Jordan Levy</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$22.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Gregory Lewis</td>
<td>BTIG</td>
<td>Raises</td>
<td>Buy</td>
<td>$30.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Ben Kallo</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$32.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Chip Moore</td>
<td>Roth MKM</td>
<td>Announces</td>
<td>Neutral</td>
<td>$25.00</td>
<td>-</td>
</tr>
<tr>
<td>Julien Dumoulin-Smith</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Underperform</td>
<td>$20.00</td>
<td>$7.00</td>
</tr>
<tr>
<td>Biju Perincheril</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Positive</td>
<td>$33.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Manav Gupta</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$33.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Lloyd Byrne</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$22.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Kashy Harrison</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$30.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Samantha Hoh</td>
<td>HSBC</td>
<td>Announces</td>
<td>Hold</td>
<td>$24.50</td>
<td>-</td>
</tr>
<tr>
<td>Chris Dendrinos</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$28.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Stephen Byrd</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$28.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Biju Perincheril</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Positive</td>
<td>$20.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Gregory Lewis</td>
<td>BTIG</td>
<td>Raises</td>
<td>Buy</td>
<td>$20.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Kashy Harrison</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$20.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Ameet Thakkar</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$19.50</td>
<td>$12.00</td>
</tr>
<tr>
<td>Biju Perincheril</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Positive</td>
<td>$16.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Ben Kallo</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$15.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Julien Dumoulin-Smith</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$7.00</td>
<td>$8.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Bloom Energy. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Bloom Energy compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Bloom Energy's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Bloom Energy's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/BE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Bloom Energy analyst ratings.</a>
<h2>Unveiling the Story Behind Bloom Energy</h2>
Bloom Energy designs, manufactures, sells, and installs solid-oxide fuel cell systems ("Energy Servers") for on-site power generation. Bloom Energy Servers are fuel-flexible and can use natural gas, biogas, and hydrogen to create 24/7 electricity for stationary applications. In 2021, the company announced plans to leverage its technology and enter the electrolyzer market. Bloom primarily sells its systems in the United States and internationally.
<h3>Bloom Energy's Economic Impact: An Analysis</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Growth: Bloom Energy's revenue growth over a period of 3 months has faced challenges. As of 30 September, 2024, the company experienced a revenue decline of approximately -17.46%. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Net Margin: Bloom Energy's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of -4.45%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -3.44%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Bloom Energy's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of -0.57%, the company showcases efficient use of assets and strong financial health.
Debt Management: Bloom Energy's debt-to-equity ratio surpasses industry norms, standing at 3.93. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>The Significance of Analyst Ratings Explained</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Assessing Bloom Energy: Insights From 21 Financial Analysts

Press Releases

Aileron Therapeutics Announces Rebranding to Rein Therapeutics

ALRN

RNTX

<h3>Gainers</h3>
<ul>
<li>Evaxion Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVAX#NASDAQ">EVAX</a>) stock increased by 87.1% to $6.81 during Friday's pre-market session. The market value of their outstanding shares is at $39.9 million. </li>
<li>Aclarion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACON#NASDAQ">ACON</a>) stock moved upwards by 63.19% to $0.07. The market value of their outstanding shares is at $1.6 million. </li>
<li>Dogwood Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DWTX#NASDAQ">DWTX</a>) shares moved upwards by 30.26% to $17.39. The market value of their outstanding shares is at $23.1 million. </li>
<li>TransCode Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) stock rose 15.45% to $6.35. The market value of their outstanding shares is at $4.4 million. </li>
<li>Avenue Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATXI#NASDAQ">ATXI</a>) shares moved upwards by 11.95% to $2.06. The market value of their outstanding shares is at $4.2 million. </li>
<li>Rein Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNTX#NASDAQ">RNTX</a>) stock increased by 11.81% to $2.46. The company's market cap stands at $53.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Sophia Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOPH#NASDAQ">SOPH</a>) shares fell 31.2% to $2.98 during Friday's pre-market session. The company's market cap stands at $194.8 million. </li>
<li>Jupiter Neurosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JUNS#NASDAQ">JUNS</a>) stock decreased by 15.18% to $1.23. The market value of their outstanding shares is at $40.7 million. </li>
<li>Quoin Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNRX#NASDAQ">QNRX</a>) stock decreased by 12.5% to $0.36. The market value of their outstanding shares is at $2.9 million. </li>
<li>Semler Scientific (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMLR#NASDAQ">SMLR</a>) stock decreased by 11.7% to $54.0. The market value of their outstanding shares is at $518.2 million. </li>
<li>Cardio Diagnostics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDIO#NASDAQ">CDIO</a>) stock declined by 8.0% to $0.46. The market value of their outstanding shares is at $18.6 million. </li>
<li>Actuate Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACTU#NASDAQ">ACTU</a>) shares fell 7.28% to $10.2. The market value of their outstanding shares is at $199.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACON

ACTU

ATXI

CDIO

DWTX

EVAX

JUNS

QNRX

RNAZ

SMLR

SOPH

12 Health Care Stocks Moving In Friday's Pre-Market Session

Rebrand to Rein Therapeutics is representative of the Company's sole focus in developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assetsCompany shares to begin trading on Nasdaq under the trading symbol "RNTX" effective January 13, 2025AUSTIN, Texas, Jan. 10, 2025 /PRNewswire/ --&nbsp;Rein Therapeutics ("Rein") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNTX#NASDAQ">RNTX</a>), formerly known as Aileron Therapeutics, Inc. ("Aileron") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALRN#NASDAQ">ALRN</a>), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications, today announced that it has changed its name to Rein Therapeutics, Inc. The new name, logo, website, and branding elements reflect the Company's mission to develop first-in-class treatments to rein in diseases. The Company's common stock will begin trading under the Nasdaq ticker symbol "RNTX" effective January 13, 2025. The CUSIP number for the Company's common stock is not affected by the name change. The Company also highlighted its recent clinical and corporate achievements and provided its key strategic objectives for 2025.

Aileron Therapeutics Announces Rebranding To Rein Therapeutics; Company Shares To Begin Trading On Nasdaq Under The Trading Symbol "RNTX" Effective January 13, 2025

Comments

Rein Therapeutics

News

Latest news for Rein Therapeutics (NASDAQ:RNTX) Stock

Friday, January 24, 2025

Friday, January 10, 2025

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga